Antisense oligonucleotides: Towards clinical trials

被引：253

作者：

Agrawal, S

机构：

来源：

TRENDS IN BIOTECHNOLOGY | 1996年 / 14卷 / 10期

关键词：

D O I：

10.1016/0167-7799(96)10053-6

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Antisense oligonucleotides have the ability to selectively block disease-causing genes, thereby inhibiting production of disease-associated proteins. The specificity and application of antisense oligonucleotides have been strongly validated in animal models for various disease targets. Based on the pharmacological, pharmacodynamic and pharmacokinetic profiles, the first generation of antisense oligonucleotides - phosphorothioates - have reached the stage of human clinical trials for various diseases, While ongoing human clinical trials are being carried out to further establishing the safety and efficacy of these oligonucleotides, the experience gained is providing a basis for designing a second generation of antisense oligonucleotides.

引用

收藏

页码：376 / 387

页数：12

相关论文

共 93 条

[71] EXOGENOUS S-35-LABELED HEPARIN - ORGAN DISTRIBUTION AND METABOLISM [J].

STAU, T ;

METZ, J ;

TAUGNER, R .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1973, 280 (01) :93-102

[72] ENZYMATIC-SYNTHESIS OF STEREOREGULAR (ALL RP) OLIGONUCLEOTIDE PHOSPHOROTHIOATE AND ITS PROPERTIES [J].

TANG, JY ;

ROSKEY, A ;

LI, Y ;

AGRAWAL, S .

NUCLEOSIDES & NUCLEOTIDES, 1995, 14 (3-5) :985-990

[73] CAPPED OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES - PHARMACOKINETICS AND STABILITY IN MICE [J].

TEMSAMANI, J ;

TANG, JY ;

AGRAWAL, S .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1992, 660 :318-320

[74] CELLULAR UPTAKE OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES AND THEIR ANALOGS [J].

TEMSAMANI, J ;

KUBERT, M ;

TANG, JY ;

PADMAPRIYA, A ;

AGRAWAL, S .

ANTISENSE RESEARCH AND DEVELOPMENT, 1994, 4 (01) :35-42

[75] INTRACELLULAR AVAILABILITY OF UNMODIFIED, PHOSPHOROTHIOATED AND LIPOSOMALLY ENCAPSULATED OLIGODEOXYNUCLEOTIDES FOR ANTISENSE ACTIVITY [J].

THIERRY, AR ;

DRITSCHILO, A .

NUCLEIC ACIDS RESEARCH, 1992, 20 (21) :5691-5698

[76] TRANSIENT DECREASE IN HIGH BLOOD-PRESSURE BY IN-VIVO TRANSFER OF ANTISENSE OLIGODEOXYNUCLEOTIDES AGAINST RAT ANGIOTENSINOGEN [J].

TOMITA, N ;

MORISHITA, R ;

HIGAKI, J ;

AOKI, M ;

NAKAMURA, Y ;

MIKAMI, H ;

FUKAMIZU, A ;

MURAKAMI, K ;

KANEDA, Y ;

OGIHARA, T .

HYPERTENSION, 1995, 26 (01) :131-136

[77]

Toulon P., 1995, Blood, V86, p889A

[78] ANTISENSE GENE INHIBITION BY OLIGONUCLEOTIDES CONTAINING C-5 PROPYNE PYRIMIDINES [J].

WAGNER, RW ;

MATTEUCCI, MD ;

LEWIS, JG ;

GUTIERREZ, AJ ;

MOULDS, C ;

FROEHLER, BC .

SCIENCE, 1993, 260 (5113) :1510-1513

[79] DELIVERY OF ANTISENSE OLIGODEOXYRIBONUCLEOTIDES AGAINST THE HUMAN EPIDERMAL GROWTH-FACTOR RECEPTOR INTO CULTURED KB CELLS WITH LIPOSOMES CONJUGATED TO FOLATE VIA POLYETHYLENE-GLYCOL [J].

WANG, S ;

LEE, RJ ;

CAUCHON, G ;

GORENSTEIN, DG ;

LOW, PS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) :3318-3322

[80] ANTISENSE OLIGODEOXYNUCLEOTIDE INHIBITS D(2)-DOPAMINE RECEPTOR-MEDIATED BEHAVIOR AND D(2)-MESSENGER RNA [J].

WEISS, B ;

ZHOU, LW ;

ZHANG, SP ;

QIN, ZH .

NEUROSCIENCE, 1993, 55 (03) :607-612

← 1 2 3 4 5 6 7 8 9 10 →